Page 44 - மார்டின் லூதர் பல்கலைக்கழகம் ஹால் விட்டன்பெர்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 E-Mail A new substance could improve the treatment of persistent cancers. Researchers at Martin Luther University Halle-Wittenberg (MLU) and the University of Greifswald have developed a new inhibitor that makes drug-resistant tumour cells respond again to chemotherapy. The new substance blocks a protein in the cancer cells that normally transports the cancer drugs back out of the cells. The results were published in the scientific journal Molecules. In addition to radiation therapy, cytotoxic agents, also known as chemotherapy, are frequently used to treat cancer. They prevent cells from dividing and thus cancer cells are unable to multiply unchecked. Cytotoxic agents remain a very important form of treatment because they have a general effect, in other words, they work on different types of cancer, explains Dr Andreas Hilgeroth, a professor of pharmacy at MLU. However, some tumours are resistant to chemotherapy. They possess certain proteins that transport the drugs back ou

Christoph ritterAndreas hilgerothUniversity of greifswaldInstitute of pharmacyResearchers at martin luther university halle wittenbergMartin luther university halle wittenbergProfessor christoph ritterPharmaceutical sciencesMedicine healthPharmaceutical sciencePharmaceutical chemistryகிறிஸ்டோஃப் ரிடர்பல்கலைக்கழகம் ஆஃப் க்ரீஃப்ஸ்‌வால்ட்நிறுவனம் ஆஃப் மருந்தகம்ஆராய்ச்சியாளர்கள் இல் மார்டின் லூதர் பல்கலைக்கழகம் ஹால் விட்டன்பெர்க்மார்டின் லூதர் பல்கலைக்கழகம் ஹால் விட்டன்பெர்க்